P1170: CAR-T THERAPY IS EFFECTIVE AND SAFE IN TREATING RELAPSED/REFRACTORY LYMPHOMA WITH MALIGNANT SEROUS CAVITY EFFUSION

por Huang, Lefu, Lu, Peihua
Publicado 2023

Expression of Lymphocyte-Activation Gene 3 (LAG-3) Immune Checkpoint Receptor Identifies a Tumor-Reactive T Cell Population in the Peripheral Blood of Patients with Colorectal Canc...

por Huang, Lefu, Qiao, Guoliang, Wu, Jiangping, Ren, Jun
Publicado 2019

Retracted: Expression of Lymphocyte-Activation Gene 3 (LAG-3) Immune Checkpoint Receptor Identifies a Tumor-Reactive T Cell Population in the Peripheral Blood of Patients with Colo...

por Huang, Lefu, Qiao, Guoliang, Wu, Jingping, Ren, Jun
Publicado 2019

Methylation silencing CDH23 is a poor prognostic marker in diffuse large B-cell lymphoma

por Cao, Baoping, Guo, Xiaochuan, Huang, Lefu, Wang, Bin, Wang, Weixia, Han, Dong, Zhang, Weijing, Zhong, Kaili
Publicado 2021

Predictive significance of T cell subset changes during ex vivo generation of adoptive cellular therapy products for the treatment of advanced non-small cell lung cancer

por Huang, Lefu, Qiao, Guoliang, Morse, Michael A., Wang, Xiaoli, Zhou, Xinna, Wu, Jiangping, Hobeika, Amy, Ren, Jun, Lyerly, Herbert K.
Publicado 2019

Safety and Efficacy of Humanized Versus Murinized CD19 and CD22 CAR T-Cell Cocktail Therapy for Refractory/Relapsed B-Cell Lymphoma

por Huang, Lefu, Li, Jingjing, Yang, Junfang, Zhang, Xian, Zhang, Min, He, Jiujiang, Zhang, Gailing, Li, Wenqian, Wang, Hui, Li, Jianqiang, Lu, Peihua
Publicado 2022

Restored CD8(+)PD-1(+) T Cells Facilitate the Response to Anti-PD-1 for Patients With Pancreatic Ductal Adenocarcinoma

por Zhu, Qian, Qiao, Guoliang, Huang, Lefu, Xu, Chang, Guo, Deliang, Wang, Shuo, Zhao, Jing, Song, Yuguang, Liu, Bing, Chen, Zheng, Yang, Zhiyong, Yuan, Yufeng
Publicado 2022